Jenburkt Pharmaceuticals Complete Financial Statements
JENBURPH • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Jenburkt Pharmaceuticals (JENBURPH).
Downloads include all available records across all periods.
For market performance, see the
JENBURPH stock price today
.
Profitability Ratios
Net Profit Margin
20.25%
2025 data
EBITDA Margin
29.75%
2025 data
Operating Margin
27.00%
2025 data
Return on Assets
16.33%
2025 data
Return on Equity
18.60%
2025 data
Balance Sheet Ratios
Current Ratio
9.50
2025 data
Debt to Equity
1.14
2025 data
Equity Ratio
87.76%
2025 data
Asset Turnover
0.81
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
+5.7%
Year-over-Year
Net Profit Growth
+3.1%
Year-over-Year
EBITDA Growth
+4.3%
Year-over-Year
Expense Growth
+5.4%
Year-over-Year
Assets Growth
+18.8%
Year-over-Year
Equity Growth
+18.6%
Year-over-Year
Liabilities Growth
+18.8%
Year-over-Year
Operating Cash Flow Growth
+250.0%
Year-over-Year
Investing Cash Flow Growth
-1600.0%
Year-over-Year
Financing Cash Flow Growth
-14.3%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 167 | 158 | 147 | 142 | 129 | 114 | 123 | 126 | 118 | 106 | 96 | 87 |
| Expenses | 117 | 111 | 109 | 106 | 97 | 90 | 99 | 98 | 91 | 84 | 77 | 70 |
| EBITDA | 49 | 47 | 38 | 36 | 32 | 24 | 24 | 28 | 27 | 23 | 19 | 17 |
| Operating Profit Margin % | 26.00% | 27.00% | 23.00% | 22.00% | 22.00% | 18.00% | 17.00% | 20.00% | 21.00% | 19.00% | 18.00% | 18.00% |
| Depreciation | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 3 |
| Interest | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 46 | 44 | 35 | 33 | 30 | 22 | 21 | 27 | 25 | 21 | 17 | 14 |
| Tax | 13 | 12 | 9 | 8 | 8 | 5 | 6 | 7 | 8 | 7 | 6 | 5 |
| Net Profit | 33 | 32 | 26 | 25 | 22 | 17 | 15 | 20 | 17 | 14 | 11 | 10 |
| Earnings Per Share (₹) | 74.80 | 72.65 | 58.86 | 53.90 | 48.58 | 35.96 | 32.40 | 43.14 | 37.50 | 29.05 | 23.18 | 20.75 |
Related Pages for Jenburkt Pharmaceuticals
Additional stock information and data for JENBURPH
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 196 | 165 | 142 | 143 | 121 | 104 | 103 | 78 | 76 | 58 | 61 |
| Current Assets | 57 | 110 | 81 | 76 | 80 | 90 | 90 | 66 | 64 | 45 | 49 |
| Fixed Assets | 15 | 10 | 10 | 11 | 11 | 12 | 10 | 10 | 11 | 12 | 12 |
| Capital Work in Progress | 40 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Investments | 21 | 17 | 11 | 8 | 7 | 4 | 5 | 5 | 2 | 0 | 0 |
| Other Assets | 121 | 137 | 119 | 123 | 104 | 88 | 87 | 63 | 64 | 46 | 49 |
| LIABILITIES | |||||||||||
| Total Liabilities | 196 | 165 | 142 | 143 | 121 | 104 | 103 | 78 | 76 | 58 | 61 |
| Current Liabilities | 6 | 4 | 4 | 4 | 5 | 5 | 3 | 3 | 4 | 4 | 4 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 172 | 145 | 122 | 117 | 99 | 80 | 78 | 61 | 54 | 40 | 33 |
| Share Capital | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves & Surplus | 167 | 141 | 118 | 113 | 94 | 75 | 73 | 57 | 50 | 36 | 29 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 28 | 8 | 17 | 9 | 20 | 15 | 13 | 16 | 10 | 8 | 9 |
| Investing Activities | -17 | -1 | 3 | -1 | -19 | -3 | -11 | 1 | -10 | 0 | 1 |
| Financing Activities | -8 | -7 | -21 | -6 | -1 | -11 | -2 | -18 | 1 | -5 | 1 |
| Net Cash Flow | 3 | 1 | -1 | 3 | 0 | 1 | 0 | -1 | 1 | 2 | 11 |